Aoki Diabetes Research Institute
The Aoki Diabetes Research Institute (ADRI) in Sacramento, California is a non-profit organization dedicated to research in the areas of diabetes and metabolism. The main focus of current research is a unique type of insulin therapy for the treatment of diabetes. It's called metabolic activation therapy (MAT) or Chronic Intermittent Intravenous Insulin Therapy (CIIIT).*
The addition of chronic intermittent intravenous insulin therapy, to the American Diabetes Association recommended treatment program can reduce hypoglycemic attacks (dangerously low blood sugar) and reduce or delay many complications of diabetes.
Diabetic complications such as kidney damage, progressive damage to the retina of the eye, orthostatic hypotension (low blood pressure), foot ulcers, gastroparesis (slow emptying of the stomach) and painful neuropathy of the feet and legs, have been stabilized or dramatically improved by adding CIIIT to standard therapy.
* CIIIT has been called many different names: hepatic activation, metabolic activation, pulsatile intravenous insulin therapy, PIVIT, pulsatile therapy, pulsatile activation therapy, PAT, and chronic intermittent intravenous therapy.